Background To gain a global perspective on short-acting β2-agonist (SABA) prescriptions
and associated asthma-related clinical outcomes in patients with asthma, we assessed …

Concerns regarding the safety of beta-2 agonists have led to revisions of the major asthma
guidelines to better address these issues. Although these updates allow for a combination of …

Asthma is the most common chronic respiratory disease in the UK; however, the
misdiagnosis rate is substantial. The lack of consistency in national guidelines and the …

Background Although socioeconomic impact on asthma control has been investigated, little
is known about its relationship to specialist referral of patients with possible severe asthma …

Background The coronavirus disease 2019 (COVID-19) pandemic period is experiencing
better asthma control, fewer exacerbations, and health care utilization, with limited data on …

Background Data regarding medication adherence in older adults with asthma before and
during the coronavirus disease 2019 (COVID-19) pandemic are lacking. Objective To …

Background Patients with asthma use short-acting β-agonists (SABA) to relieve symptoms
but SABA alone does not treat underlying inflammation. Thus, over-reliance on SABA may …

Purpose Machine learning models informed by sensor data inputs have the potential to
provide individualized predictions of asthma deterioration. This study aimed to determine if …

The integration of technology into health care has shown significant promise in enhancing
patient adherence, particularly in the field of allergy/immunology. This article explores the …

Background In recent years, there has been a growing interest in the utilization of biologic
therapies for the management of asthma. Both TSLP and IgE are important immune …